Filing Details
- Accession Number:
- 0001179110-15-014746
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-12 11:29:41
- Reporting Period:
- 2015-11-09
- Filing Date:
- 2015-11-12
- Accepted Time:
- 2015-11-12 11:29:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 896264 | Usana Health Sciences Inc | USNA | Medicinal Chemicals & Botanical Products (2833) | 870500306 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1636394 | Rick Stambaugh | 3838 W Parkway Blvd Salt Lake City UT 84120 | Chief Information Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-11-09 | 1,000 | $45.91 | 1,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-11-09 | 1,000 | $135.00 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-11-09 | 2,053 | $45.91 | 2,053 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-11-09 | 2,053 | $130.24 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-11-10 | 200 | $45.91 | 200 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-11-10 | 200 | $130.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock-Settled Stock Appreciations Rights | Disposition | 2015-11-09 | 1,516 | $45.91 | 1,516 | $45.91 |
| Common Stock | Stock-Settled Stock Appreciations Rights | Disposition | 2015-11-09 | 3,174 | $45.91 | 3,174 | $45.91 |
| Common Stock | Stock-Settled Stock Appreciations Rights | Disposition | 2015-11-10 | 310 | $45.91 | 310 | $45.91 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,484 | 2017-10-22 | 2018-04-22 | No | 4 | M | Direct |
| 10,310 | 2017-10-22 | 2018-04-22 | No | 4 | M | Direct |
| 10,000 | 2017-10-22 | 2018-04-22 | No | 4 | M | Direct |
Footnotes
- The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.
- Weighted average price. Price range in multiple transactions was $130.00 to $130.51, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.
Billionaire Hedge Funds
